Press Releases

DMC Secures $18M to Expand Health Ingredients Business

MORRISVILLE, NC — October 26, 2026 — DMC Biotechnologies (DMC), a U.S.-based health ingredient company developing high-purity, science-backed bioactives through precision fermentation, today announced that it has secured $18 M in financing. The financing was co-led by Inceptional Partners and Sofinnova Partners with strong participation from First Bight Ventures, and existing investors Cibus Capital and Capricorn Partners.

Biotech Open Platform Inaugurates Its Biotechnology Platform

Sep 29, 2026

Biotech Open Platform Inaugurates Its Biotechnology Platform, Opening a New Chapter for Industrial Innovation in Europe Two years after its creation by Danone, Michelin, DMC Biotechnologies, Crédit Agricole Centre France, Clermont Auvergne Innovation and Greentech,...

LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market

Apr 7, 2026

BOULDER, CO — April 07, 2026 — LBB Specialties (LBBS), a North American distributor of specialty chemicals and ingredients providing technical solutions with a customer-first approach, today announced a new partnership with DMC Biotechnologies (DMC), a U.S.-based...

DMC Debuts Industry-First Fermented D-Chiro-Inositol

Jul 15, 2025

A next-generation nutraceutical ingredient—cleaner, more sustainable, and ready for modern formulation needs. BOULDER, CO — July 15, 2025 — DMC Biotechnologies (DMC), a leading U.S.-based biomanufacturer, announces the commercial launch of D-chiro-inositol. This new...

Toyobo and DMC Sign JDA to Advance Sustainable Chemical Solutions

Jun 3, 2025

Boulder, CO and Osaka, Japan – June 3, 2025 – DMC Biotechnologies, Inc. (DMC) and Toyobo Co., Ltd. (Toyobo) have entered into a multi-year collaboration agreement to develop a more sustainable, fermentation-produced, high volume chemical intermediate for use in a wide...

« Older Entries